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Members of the genus Bacteroides, mainly Bacteroides fragilis, can cause severe disease in man,
especially after intestinal perforation in the course of abdominal surgery. Treatment is based on a
small number of antibiotics, including metronidazole, which has proved to be highly reliable
throughout the last 40 to 50 years. Nevertheless, metronidazole resistance does occur in
Bacteroides and has been mainly attributed to Nim proteins, a class of proteins with a suggested
nitroreductase function. Despite the potentially high importance of Nim proteins for human health,
information on the expression of nim genes in B. fragilis is still lacking. It was the aim of this study
to demonstrate expression of nim genes in B. fragilis at the protein level and, furthermore, to
correlate Nim levels with the magnitude of metronidazole resistance. By the application of 2D gel
electrophoresis, Nim proteins could be readily identified in nim-positive strains, but their levels
were not elevated to a relevant extent after induction of resistance with high doses of
metronidazole. Thus, the data herein do not provide evidence for Nim proteins acting as
nitroreductases using metronidazole as a substrate, because no correlation between Nim levels
and levels of metronidazole resistance could be observed. Furthermore, no evidence was found
that Nim proteins protect B. fragilis from metronidazole by sequestering the activated antibiotic.
INTRODUCTION
The intestinal bacteria of the genus Bacteroides account for
as much as 30%, approximately, of human faecal isolates
(Kuwahara et al., 2004) and utilize carbohydrate sources
that are inaccessible to the human host. In general, Bac-
teroides spp. are beneficial to the host by producing volatile
fatty acids that can be absorbed through the large intestine
(Wexler, 2007). However, Bacteroides spp., predominantly
Bacteroides fragilis, can also cause severe disease, especially
after abdominal surgery or injury of the gastrointestinal
tract (Aldridge & Sanders, 2002). Main symptoms include
abscess formation (abdomen, liver, brain, lungs) and/or
bacteraemia (Wexler, 2007). Treatment schemes mainly
rely on ampicillin/sulbactam, clindamycin, carbapenems
and the 5-nitroimidazole drug metronidazole (Wexler,
2007). Presently, carbapenems and metronidazole are the
most reliable treatment options because resistance rates
have remained very low (Hedberg & Nord, 2003; So´ki et al.,
2013). Nevertheless, metronidazole-resistant Bacteroides
isolates have been repeatedly isolated and seem to be
relatively common even in some parts of the world, e.g. in
the UK (Brazier et al., 1999). In most cases, metronidazole
resistance is associated with the presence of nim genes,
which were first described as transmissible metronidazole-
resistance determinants (Breuil et al., 1989). They can be
either chromosomal or plasmid borne, and are often, but
not always, associated with insertion elements (So´ki et al.,
2006). To date, ten isoforms of nim have been described,
nimA–J (Gal & Brazier, 2004; Husain et al., 2013), but there
is currently no evidence that they act differently. In fact,
the mode of action of Nim proteins has not been fully
elucidated as yet, but they are commonly believed to act as
nitroreductases, which reduce the nitroimidazole drug’s
nitro group to a barely reactive amino group (Carlier et al.,
1997). In contrast with this notion, however, only a fraction
of nim-positive strains are metronidazole resistant (Gal &
Brazier, 2004; Lo¨fmark et al., 2005), and the introduction of
nimE and nimJ into B. fragilis 638R had only a very modest
effect on metronidazole susceptibility (Husain et al., 2013).
This discrepancy can possibly be reconciled by the obser-
vation that induction of high-level metronidazole resistance
is far easier in nim-positive Bacteroides isolates than in nim-
negative isolates (Lo¨fmark et al., 2005), suggesting elevated
Nim expression in challenged isolates. Evidence for this,
however, is presently lacking as no Nim expression studies
have been conducted to date.
Abbreviation: 2DE, 2D gel electrophoresis.
One supplementary figure is available with the online version of this
paper.
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The present study aimed at filling this gap, and thereby
constitutes what is to the best of our knowledge a first
attempt to correlate Nim levels as such to metronidazole
resistance. To this end, several B. fragilis isolates carrying a
nim gene were studied by 2D gel electrophoresis (2DE) in
order to quantify abundancies of Nim. Furthermore, it was
assessed whether nim gene levels are being upregulated in
response to exposure to ever increasing concentrations
of metronidazole. The data presented here may prove
instrumental for a further assessment of the role of nim
genes in the development of metronidazole resistance in
Bacteroides spp.
METHODS
Chemicals and growth media components. Metronidazole,
tinidazole, haemin, DTT, CHAPS, urea, thiourea, acetone, TCA
and bisacrylamide were obtained from Sigma-Aldrich. Brain heart
infusion (BHI) broth and vitamin K1 were purchased from Carl Roth.
Wilkins–Chalgren (WC) anaerobe agar was purchased from Oxoid.
Acrylamide, IPG (immobilized pH gradient) strips for IEF, ampho-
lytes and iodoacetamide were purchased from Bio-Rad. Yeast extract
and Anaerocult A for anaerobic culture were obtained from Merck.
Coomassie brilliant blue was purchased from Serva.
Bacterial strains and culture. The following B. fragilis strains
were used for this study: 638R, either without plasmid or with either
pIP417 (nimA) or pIP421 (nimD); BF-8 (nimB, chromosomal); and
388/1 (nimE on plasmid pBF388C). The nimA gene on pIP417 is
associated with IS1186, whereas nimD on pIP421 is associated with
IS1169. The nimB gene in BF-8 had been found to be associated with
an IS1186-like insertion element (Haggoud et al., 1994), and nimE on
pBF388C is associated with an IS-like element (ISBf6). Strains BF-8
(Sebald et al., 1990; So´ki et al., 2004, 2006) and 388/1 (So´ki et al.,
2004; 2006) had been found to be resistant to 8 mg metronidazole l21
and 16 mg metronidazole l21, respectively.
Cultures were routinely grown in anaerobic jars on WC plates
at 37 uC. When batch cultures were needed for 2DE, bacteria were
grown in 25 ml tissue culture flasks (Falcon; Becton Dickinson) in
BHI broth supplemented with 0.5% yeast extract, 5 mg haemin l21
and 1 mg vitamin K l21 (BHI-S), as described by Jousimies-Somer
& Summanen (2002). Bacterial culture was carried out in anaerobic
jars (Merck) using the Anaerocult A system.
Induction of high-level metronidazole resistance in B. fragilis
and determination of MIC. High-level resistance was induced by
growing strains on a series of WC agar plates with increasing concen-
trations of metronidazole until a maximal concentration of 256 mg l21
was reached. The concentration of metronidazole in the plates was
increased in doubling steps, i.e. 1, 2, 4, 8, 16, 32, 64, 128 and finally
256 mg l21. The MIC was defined as the lowest metronidazole concen-
tration at which no more B. fragilis growth on WC plates could be
observed.
Exposure of B. fragilis 638R batch cultures to metronidazole.
After 16 h, stationary phase cultures (20 ml) were divided equally into
two 25 ml culture flasks and 10 ml fresh BHI-S was added to both
flasks. Either 50 mM metronidazole or 50 mM tinidazole was added to
one of the cultures, followed by 2 h incubation in an anaerobic jar at
37 uC. Afterwards, samples were processed as described below.
Sample preparation for 2DE. Bacteroides fragilis cultures (20 ml)
were harvested at 3000 g for 10 min at 4 uC in a Sigma 4K15
centrifuge. The pellet was resuspended and washed in 16PBS and
repelleted again at 3000 g for 10 min at 4 uC. Bacteria were then
resuspended in a small volume (400 ml) of ultrapure water, and
proteins were precipitated by adding 12.5% TCA in acetone to the
sample until a final concentration of 10% TCA was reached. Proteins
were precipitated for at least 1 h at 220 uC. The precipitates were
pelleted in a Sigma 1-15PK cryo-centrifuge (20 000 g, 20 min, 4 uC)
and pellets were washed in 90% acetone (20 000 g, 20 min, 4 uC).
Pellets were then dried and resuspended in 2DE sample buffer (7 M
urea, 2 M thiourea, 4% CHAPS, 1% DTT, 1% ampholytes, pH 3–
10) for at least 3 h. Insoluble matter was removed by centrifugation at
20 000 g for 20 min at 20 uC. The protein concentration in the
supernatant was determined by Bradford assay (Bradford, 1976), and
400 mg protein was used for 2DE.
2DE. IEF was performed in 17 cm IPG strips with pH 3–10 nonlinear
(Bio-Rad) and a Protean IEF cell (Bio-Rad), using the following
program: 12 h rehydration at 50 V, 1 h 150 V (rapid slope), 1 h
300 V (rapid slope), 1 h 2000 V (linear slope), 2 h 5000 V (linear
slope) and 7 h 8000 V (rapid slope). After IEF, gel strips were
equilibrated in a two-step procedure in 6 M urea, 30% glycerol, 2%
SDS and 50 mM Tris pH 8.8 containing either 1% DTT (first step) or
4% iodoacetamide (second step). Strips were run vertically in a
Protean II xi cell (Bio-Rad) at 22 mA overnight (4 uC). After gel
electrophoresis, gels were stained with Coomassie brilliant blue R-250
and scanned in an Epson V750 Pro scanner. Image analysis was
performed using Melanie 4 software (GeneBio).
In-gel tryptic digestion and mass-spectrometric analysis of
isolated proteins. Tryptic digestion of Coomassie-stained protein
spots was performed by reversed phase LC ESI-ion trap MS-MS on a
Bruker amaZon ETD speed ion trap (Bruker Daltonics) coupled to a
Dionex Ultimate 3000 UHPLC system (Dionex–ThermoFisher) as
described previously (Kolarich et al., 2012), with minor modifications
as given in detail in Fig. S1, available in the online Supplementary
Material.
Data analysis was performed with ProteinScape 3 (Bruker Daltonics)
and MASCOT 2.3 (MatrixScience) using the following search para-
meters: cysteine as carbamidomethyl was set as fixed modification,
while deamidation (Asn/Gln) and oxidation (Met) were set as variable
modifications. A maximum of two missed cleavages were allowed.
Peptide tolerance (both MS and MS-MS) was set at ±0.2 Da. The
data were searched against the National Center for Biotechnology
Information protein database.
Quantitative PCR analysis of the effect of metronidazole on
plasmid copy number. Copy numbers of the nimA gene in B. fragilis
638R/pIP417 were determined by the DDCT method using SYBR
Green detection, the housekeeping gene glyceraldehyde-phosphate
dehydrogenase (gap) as a reference, and the pIP417 repA and nimA
genes as target genes. Copies of the nimA gene in clones of 638R/
pIP417 adapted to 2 mg metronidazole ml21 and 256 mg metronida-
zole ml21 (adaptation to metronidazole having been carried out as
described above) were measured using unchallenged B. fragilis 638R/
pIP417 as the control. Samples were prepared by the boiling method
(So´ki et al., 2013) and the primers used were as follows: gap, gapd1BF
59-AGCCATTGTAGCAGCTTTTT-39 and gapd3BF 59-GAAAACAT-
CATCCCGTCT-39; repA417, repA417-1 59-TGAGCAACCAGAAAA-
CTC-39 and repA417-2 59-TTTTTGCAGCATCCACAA-39; and nimA,
nimART1 59-GTTCCTGCCGAGTTTACAAC-39 and nimART2 59-
GATGGTCGAATCCCTTGTCT-39. The PCRs included 5 ml SYBR
Select mastermix (Life Technologies), 0.7 mM primers and 1 ml of
template preparations in 10 ml final volumes in triplicate in 48-well
PCR plates. Amplifications (95 uC 10 min; 35 cycles 95 uC 15 s, 57 uC
15 s, 72 uC 30 s; and a melting curve from 72 uC to 95 uC) and
analysis were carried out with a StepOne real time-PCR instrument
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(Life Technologies) and by the accompanying software (StepOne
Software 2.1; Life Technologies).
Growth curve determinations of B. fragilis 638R with and
without pIP417 (nimA). Growth of the B. fragilis strain 638R and the
same strain with the pIP417 plasmid was observed by densitometry at
600 nm using a UV/VIS spectrophotometer (BioMate; Thermo
Electron). Briefly, stationary cultures of the strains in BHI-S broth
were diluted 40-fold in parallel in 3 ml aliquots into three glass test
tubes of the same media and subsequently incubated anaerobically
(BugBox; Ruskinn Technology) at 37 uC. After 5, 10, 15, 20, 25 and
30 h, aliquots in separate tubes were taken out from anaerobiosis,
appropriately diluted to obtain OD600 readings in the range 0.2–0.6,
and their optical densities recorded.
RESULTS AND DISCUSSION
NimA, NimB, NimD and NimE are clearly
expressed, and can be visualized by 2DE
In order to demonstrate that nim genes are in fact expressed
at the protein level, 2DE was performed with cultures of
several B. fragilis strains that harbour a nim gene (Table 1).
As a first step, strain B. fragilis 638R was analysed because
direct comparison was possible between clones without
plasmid (nim negative) and clones bearing either pIP417
(nimA) or pIP421 (nimD). The 2D gels of 638R clones,
carrying either nim gene, were searched for additional
protein spots as compared to the nim-negative clone.
Indeed, additional proteins in the expected molecular mass
range of NimA and NimD (18–20 kDa) were readily found
(Fig. 1). The proteins were isolated from the gels, analysed
by MS and identified as NimA and NimD (Fig. S1). NimA
levels, as determined densitometrically with Melanie 2DE-
imaging software in 2D gels from four different gel runs
at four different time points (four 2D gels in total),
ranged from 0.7 to 1.5% of the total protein visualized
(1.1±SEM 0.3%). Thus, the method enables reproducible
measurements of protein levels but does not allow reliable
conclusions on differences in abundance below 100%.
NimD levels were found to account for 0.58% of the total
protein visualized. NimB and NimE were also identified in
2D gels from strains BF8 and 388/1, respectively (Table 2).
Interestingly, levels of NimB (0.29% of total protein) and
NimE (0.14% of total protein) were clearly lower than
those of NimA and NimD in 638R (Table 2). In the case of
nimB, this might be attributable not only to a lower rate of
transcription and/or translation per se but also to a lower
copy number due to its chromosomal location. In contrast,
nimA, nimD and nimE are all episomal (Table 1).
Levels of NimA, NimB and NimE are not further
increased upon adaptation to high concentrations
of metronidazole
After visualization and measurement of NimA, B, D and E
levels in B. fragilis, it was assessed whether adaptation to
higher concentrations of metronidazole leads to increased
levels of Nim proteins. Since Nim proteins have been
suggested to act as nitroreductases that reduce metronidazole
and other nitroimidazole drugs to nonreactive aminoimida-
zoles (Carlier et al., 1997), their abundance is expected to be
positively correlated with the level of metronidazole resist-
ance. In order to test this, high-level metronidazole resistance
(256 mg l21) was induced in 638R (nimA), BF8 (nimB) and
388/1 (nimE). Interestingly, high-level metronidazole resist-
ance was most easily induced in 388/1, although this strain
expresses the lowest level of Nim (Table 2). The strains 638R
(nimA) and 638R (nimD) had previously grown well on
plates with 1 mg metronidazole ml21 and somewhat more
slowly on plates with 2 mg metronidazole ml21, whereas
638R (nim negative) did not grow at 1 mg metronidazole
ml21, indicating a protective effect of NimA and NimD.
High-level metronidazole resistance in 638R (nim negative)
could not be induced, and attempts to generate clones that
were resistant to metronidazole concentrations higher
than 16 mg l21 remained unsuccessful. This corroborates
previous results (Lo¨fmark et al., 2005) indicating that nim-
positive strains can be adapted to high metronidazole
concentrations much more easily than nim-negative strains.
When Nim levels were measured by 2DE in the highly
resistant clones, however, no relevant upregulation as
compared with the respective parent clones was found
(Table 2). In fact, the observed levels of Nim B and E were
slightly higher as compared to the unchallenged clones
(Table 2), but this is not statistically significant when
taking into consideration the observed variance in
Table 1. The B. fragilis strains used in this study
MIC was defined as the lowest metronidazole concentration at which further B. fragilis growth on WC plates could not be observed.
B. fragilis
strain/clone
nim gene Accession nos
of Nim proteins
Location of
nim gene
MIC of metronidazole
observed in this
study (mg l”1)
Reference
638R None – ,1 Sebald et al. (1990)
638R (nimA) nimA gi|435265 pIP417 4 Stubbs et al. (2000)
638R (nimD) nimD gi|440387 pIP421 4 Stubbs et al. (2000)
388/1 nimE gi|435261 pBF388C 32 So´ki et al. (2004)
BF8 nimB gi|70559779 Chromosome 2 Sebald et al. (1990)
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abundance of NimA in unchallenged 638R (nimA)
(1.1±0.3% of total protein visualized). Despite the lack
of correlation between Nim levels and the level of
metronidazole resistance, copy numbers of plasmid
pIP417 (nimA) were three- to fourfold higher when 638R
(nimA) was grown on plates containing metronidazole
than when grown without metronidazole (Fig. 2).
Interestingly, copy numbers of the nimA gene were not
found to be significantly increased in the 638R (nimA)
clone adapted to 256 mg metronidazole l21 when com-
pared with 638R (nimA) routinely grown with 2 mg
metronidazole l21 (Fig. 2). Therefore, the reason for the
elevated plasmid numbers in 638R (nimA) in the presence
of metronidazole is unclear. The notion of a selection of
clones with higher copy numbers in response to increasing
metronidazole concentrations is supported neither by the
measured NimA levels (Table 2) nor the insignificant
increase of plasmid numbers in the clone adapted to
256 mg metronidazole l21 as compared with the clone
adapted to 2 mg metronidazole l21. However, as metro-
nidazole is mutagenic (Sisson et al., 2000), higher copy
numbers of the nimA gene might, at least in the first phase
of the development of resistance, increase the likelihood of
retaining a copy of the gene without deleterious mutations.
It is important to note, however, that these speculations
apply only to B. fragilis strains having a plasmid-borne nim
gene, and not to those having a chromosomal nim gene,
e.g. BF8 (Table 1). Nevertheless, the selection of clones with
a higher number of chromosomal copies of nim genes can
not presently be ruled out because copy numbers of nimB
in BF8 were not determined in this study.
These considerations notwithstanding, no evidence was
found for induction of Nim levels upon exposure to
increasing doses of metronidazole, nor for a selection of
pH
MM
638R (nim–) 638R (nimA) 638R (nimD)
Fig. 1. Representative images of 2D gels (pH range 3–10 nonlinear, 12.5% polyacrylamide) from strain 638R, either without
nim gene (left image); with plasmid pIP417 (nimA, IS1186), nimA positive (middle); or with plasmid pIP421 (nimD, IS1169),
nimD positive (right). The Nim proteins (encircled) are easily discernible as prominent spots in the lower molecular mass range
of the gel. The theoretical molecular masses of NimA and NimD were 20.2 and 18.5 kDa, respectively. The directions of
increasing molecular mass (MM) and increasing pH are indicated by arrows.
Table 2. Levels of NimA, NimB and NimE before and after
induction of high-level metronidazole resistance (256 mg l”1)
Percentages refer to the relative abundance of Nim proteins as
compared to total protein visualized by 2DE. The strain carrying the
respective nim gene is indicated in parentheses.
Level Nim A
(Bf 638R)
Nim B
(BF8)
Nim E
(388/1)
Original level (%) 0.7 0.29 0.14
Induced level (%) 0.87 0.4 0.18
Metronidazole exposure (µg ml–1)
None 2 256
R
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at
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e 
co
py
 n
um
be
r
0
1
2
3
4
5
6
Fig. 2. Relative copy number determination of the nimA plasmid
(pIP417) depending on metronidazole exposure/adaptation. Error
bars indicate SEM with 95% confidence. Black bars, nimA; grey
bars, repA.
Nim expression in Bacteroides
http://mic.sgmjournals.org 619
Downloaded from www.microbiologyresearch.org by
IP:  160.114.108.46
On: Thu, 19 Oct 2017 14:01:49
clones expressing higher levels of Nim with increasing level
of resistance. In fact, given the comparably low abundance
of Nim proteins in the strains BF8 (nimB positive) and
388/1 (nimE positive), no dependence of the protective
effect of Nim proteins on copy number in the cell could be
found. It is important to note, however, that NimB and
NimE can function differently from NimA and NimD, and
that the different genetic background of BF8 and 388/1
allowed lower amounts of Nim to be as effective as the
higher amounts of NimA and NimD in 638R.
The protective effect of nim genes and an increased pro-
pensity of nim-positive strains to adapt to high metro-
nidazole concentrations (Lo¨fmark et al., 2005) remains
undisputed and is supported by our results presented here.
Although our data do not provide any support for the
notion of Nim proteins reducing metronidazole, it cannot
presently be ruled out that Nim proteins do indeed con-
tribute to metronidazole resistance but require an inducible
host factor, either an enzyme or a cofactor, for activity. In
this case it would not be the induction of Nim expression
that is critical for resistance to be demonstrated, but
induction of the hypothetical host factor. The expression
level of this host factor could vary from strain to strain,
explaining why protective levels of Nim are so variable
among different strains (Table 2). Currently, however, there
is no indication that such a host factor exists. It is also
interesting to note that all our attempts to measure the
nitroreductase activity of recombinantly expressed NimA in
vitro have so far been unsuccessful (data not shown).
NimA is not bound by metronidazole and does not
affect the growth rate of B. fragilis 638R
Since no correlation of Nim levels and the level of metro-
nidazole resistance was observed, it was hypothesized that
Nim proteins might protect sensitive target molecules in B.
fragilis from low doses of metronidazole by acting as bait
and sequestering activated metronidazole. This assumption
was mainly based on the observed high levels of Nim
(Table 2) and on the propensity of activated metronidazole
and other nitroimidazoles to form covalent adducts with
defined target proteins (Leitsch et al., 2007, 2009, 2012). As
adduct formation with metronidazole can be visualized by
2DE due to a shift in pI of the bound protein to a more
alkaline pH (Leitsch et al., 2007, 2009, 2012; Williams et al.,
2012), it was speculated that covalent adduct formation of
Nim proteins and metronidazole would be discernible on
2D gels. Alternatively, metronidazole treatment may also
lead to the degradation of target proteins, as observed with
elongation factor 1-c in Giardia lamblia (Leitsch et al.,
2012). However, when the levels and integrity of NimA in
untreated 638R (nimA) and 638R (nimA) exposed to
50 mM metronidazole for 2 h were compared, neither a
shift nor any degradation of the protein could be observed
(Fig. 3a), suggesting that NimA is not a target of metro-
nidazole and, therefore, cannot sequester activated metro-
nidazole. Importantly, adduct formation of metronidazole
with several other B. fragilis proteins was observed. Of
these, one prominent protein spot (2–3% of all protein
visualized) was isolated and analysed by MS. The isolated
spot contained four proteins of similar size and pI (Fig.
S1): a putative oxidoreductase, a putative D-3-phospho-
glycerate dehydrogenase, glutaminase and a putative
purine nucleoside phosphorylase. It was not determined
which component of the spot was bound by metronidazole,
but it is interesting to note that purine nucleoside
phosphorylase in the protist parasite Entamoeba histolytica
was previously identified as a target of metronidazole
(Leitsch et al., 2007). Formation of adducts was confirmed
in 638R (nim negative) with metronidazole and tinidazole
(Fig. 3b). Tinidazole forms covalent adducts with the same
proteins as metronidazole, but leads to narrower shifts in
0.98 %
1.03 %
3 %
1.9 % + 1 %
NimA
(a)
(b)
Isolated
protein spot
–Mtz
+Mtz
638R (nimA)
Untreated 50 mM Mtz 50 mM Tnz
638R (–nim)
Isolated
protein spot
Fig. 3. 2DE analysis of metronidazole-treated 638R. (a) Integrity and relative abundance of NimA and the putative reductase
(E1WVQ6_BACF6) were checked on 2D gels after 2 h of incubation of equally divided 638R (nimA) stationary phase cultures
either without drug or with 50 mM metronidazole. The encircled area indicates the location of the metronidazole adduct of the
isolated protein spot. Percentages refer to the relative abundance of the measured proteins as compared to total protein
visualized. (b) Validation of metronidazole adduct formation in 638R (nim negative). The encircled areas indicate adducts of the
isolated protein spot with either metronidazole or tinidazole. Mtz, metronidazole; Tnz, tinidazole.
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the pI of bound proteins, presumably due to the different
charge of its side chain (Leitsch et al., 2007, 2009, 2012;
Williams et al., 2012). Due to this easily discernible
difference with regard to the width of pI shift, tinidazole
has proven instrumental in distinguishing adduct forma-
tion from unspecific changes in proteins upon nitroimi-
dazole treatment. The extent of adduct formation observed
in 638R (nim negative) compared well to that in 638R
(nimA), further arguing against an immediate protective
effect of NimA (Fig. 3a, b).
Based on previous results, it was hypothesized that Nim
proteins might have an indirect effect on metronidazole
sensitivity, e.g. by impeding the metabolism of B. fragilis.
In fact, metabolically generated reductive power is a
prerequisite for the reduction of nitroimidazole drugs
(Samuelson, 1999). It was argued that growth rate is a
function of metabolic capacity, and growth curves of 638R
(nim negative) and 638R (nimA) were determined in BHI-S
broth and in unsupplemented BHI broth, which lack
haemin and vitamin K. However, no influence of NimA
on growth of 638R (nimA) as compared with 638R (nim
negative) could be found, with the doubling times (1.39±
0.02 h21 and 1.45±0.04 h21, respectively) and maximal
culture densities (OD600 1.52±0.02 and 1.46±0.03,
respectively) of both clones being practically identical. This
result argues against any influence of NimA on B. fragilis
metabolism.
Conclusion
This study represents what is, to the best of our knowledge,
the first attempt to quantify Nim levels in B. fragilis. No
correlation between Nim levels and the level of metroni-
dazole resistance was found, which contrasts with the
established notion of Nim proteins inactivating or seques-
tering metronidazole directly. Further studies on the func-
tion of Nim proteins will be necessary to obtain a more
reliable notion of their function.
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